Skip to content
Home/Companies/Healthcare/In2Bones
In2Bones

In2Bones

Healthcare·France·Exited 2022·Held 8yr
Entry
2014
Hold
8yr
Exit
2022

Who owns In2Bones?

In2Bones was owned by Newfund Management through Newfund I (2013 vintage) from 2014 to 2022, exited via Trade Sale.

Buyer identity available on Pro.

Hand-verified · updated 2026-06-10

Newfund Management
Investor
Newfund Management
Newfund I · 2013 · VC

Key facts

HQFrance
SectorHealthcare
StatusAcquired
Websitein2bones.eu
Exit Type
Trade Sale
Buyer
MOIC
–
Exit Year
2022

More from Newfund I

Other portfolio companies in the same fund.

Fermeate
Active
SoftwareFrance· 2026
Cleaq
Exited 2024
FinancialsFrance· 2014
to
Elues Locales
Elues Locales
Active
EnergyFrance· 2014
Gpio
Exited 2016
IndustrialsUS· 2014
to
LiveMinutes
Exited 2016
SoftwareUS· 2014
to
Quasar
Active
FinancialsUS· 2014

More PE-backed in Healthcare

Comparable healthcare deals from other GPs.

3i – Implant Innovations Inc.
Active
Advent InternationalUS
A Place for Mom
A Place for Mom
Active
Silver LakeUS
Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
Abbisko Healthcare
Active
The Carlyle GroupChina
Abode Healthcare
Active
Summit PartnersUS
AccentCare
AccentCare
Active
Advent InternationalUS
Track In2Bones

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Get the full record on In2Bones.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue